Better Times Ahead For Novo Nordisk ADR (NYSE: NVO)?
Jennison Associates LLC has recently announced that it has increased stake in Novo Nordisk ADR (NYSE:NVO) by 0.15%. After grabbing 23.42 million shares, the institutional investor is now in possession of 35609.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.68% having worth around $2.39 billion. Moreover, Fayez […]
Novo Nordisk ADR (NYSE: NVO) Stock In Prove Me State
Jennison Associates LLC has recently announced that it has increased stake in Novo Nordisk ADR (NYSE:NVO) by 0.15%. After grabbing 23.42 million shares, the institutional investor is now in possession of 35609.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.68% having worth around $2.39 billion. Moreover, Fayez […]
